Francisca Alexandra Gavilanes Oleas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Francisca Alexandra Gavilanes Oleas has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Caio Julio Cesar dos Santos Fernandes
Universidade de São Paulo
3 shared publications - Carlos Jardim
Universidade de São Paulo
2 shared publications - José Leonidas Alves-Junior
Universidade de São Paulo
2 shared publications - Luciana Tamie Kato Morinaga
Heart Institute, University of Sao Paulo Medical School; Sirio Libanes Hospital
2 shared publications - Rogerio Souza
Universidade de São Paulo
2 shared publications - Bruna Piloto
Pulmonary Division - Instituto do Coração (InCor) - Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 January 2019
- Published by FapUNIFESP (SciELO) in Jornal Brasileiro de Pneumologia
- Vol. 45 (1) , e20180297
Use of thrombolytic agents in the treatment of acute pulmonary thromboembolism: things are not as simple as you might think
- 1 January 2019
- Published by FapUNIFESP (SciELO) in Jornal Brasileiro de Pneumologia
- Vol. 45 (1) , e20180297
Open AccessUse of thrombolytic agents in the treatment of acute pulmonary thromboembolism: things are not as simple as you might think
- Open Access
- 1 May 2018
- Published by FapUNIFESP (SciELO) in Jornal Brasileiro de Pneumologia
- Vol. 44 (3) , 237-243
Reperfusion in acute pulmonary thromboembolism
Acute pulmonary thromboembolism (APTE) is a highly prevalent condition (104-183 cases per 100,000 person-years) and is potentially fatal. Approximately 20% of patients with APTE are hypotensive, being considered at high risk of death. In such patients, immediate lung reperfusion is necessary in order to reduce right ventricular afterload and to restore hemodynamic stability. To reduce pulmonary vascular resistance in APTE and, consequently, to improve right ventricular function, lung reperfusion strategies have been developed over time and widely studied in recent years. In this review, we focus on advances in the indication and use of systemic thrombolytic agents, as well as lung reperfusion via endovascular and classical surgical approaches, in APTE.
- 1 May 2018
- Published by FapUNIFESP (SciELO) in Jornal Brasileiro de Pneumologia
- Vol. 44 (3) , 237-243
Open AccessReperfusion in acute pulmonary thromboembolism
Acute pulmonary thromboembolism (APTE) is a highly prevalent condition (104-183 cases per 100,000 person-years) and is potentially fatal. Approximately 20% of patients with APTE are hypotensive, being considered at high risk of death. In such patients, immediate lung reperfusion is necessary in order to reduce right ventricular afterload and to restore hemodynamic stability. To reduce pulmonary vascular resistance in APTE and, consequently, to improve right ventricular function, lung reperfusion strategies have been developed over time and widely studied in recent years. In this review, we focus on advances in the indication and use of systemic thrombolytic agents, as well as lung reperfusion via endovascular and classical surgical approaches, in APTE.
- Open Access
- 1 April 2018
- Published by FapUNIFESP (SciELO) in Jornal Brasileiro de Pneumologia
- Vol. 44 (2) , 167
Giant pulmonary artery aneurysm in a patient with schistosomiasis-associated pulmonary arterial hypertension
We report the case of a 38-year-old male patient with a > 10-year history of schistosomiasis-associated pulmonary arterial hypertension, with compression of the aorta and coronary artery by a giant pulmonary artery aneurysm. Mean pulmonary artery pressure was 33 mmHg, pulmonary capillary pressure was 10 mmHg, and cardiac output was 6.9 L/min, without evidence of congenital heart disease or lung disease. The patient reported palpitations, dyspnea (categorized as functional class IV), and synco aop_jbp_0088_EN pe on exertion. Chest X-ray and chest CT angiography showed a giant pulmonary artery aneurysm (Figures 1A and 1B), without evidence of thromboembolism but with calcifications in the main branches of the pulmonary artery, together with partial compression of the aorta and trunk of the left coronary artery (Figures 1C and 1D). Little is known about the dynamic behavior of such large vascular dilatations,3 and their potential for complications should always be considered, especially for patients in whom the symptoms are disproportionate to the hemodynamic impairment.
- 1 April 2018
- Published by FapUNIFESP (SciELO) in Jornal Brasileiro de Pneumologia
- Vol. 44 (2) , 167
Open AccessGiant pulmonary artery aneurysm in a patient with schistosomiasis-associated pulmonary arterial hypertension
We report the case of a 38-year-old male patient with a > 10-year history of schistosomiasis-associated pulmonary arterial hypertension, with compression of the aorta and coronary artery by a giant pulmonary artery aneurysm. Mean pulmonary artery pressure was 33 mmHg, pulmonary capillary pressure was 10 mmHg, and cardiac output was 6.9 L/min, without evidence of congenital heart disease or lung disease. The patient reported palpitations, dyspnea (categorized as functional class IV), and synco aop_jbp_0088_EN pe on exertion. Chest X-ray and chest CT angiography showed a giant pulmonary artery aneurysm (Figures 1A and 1B), without evidence of thromboembolism but with calcifications in the main branches of the pulmonary artery, together with partial compression of the aorta and trunk of the left coronary artery (Figures 1C and 1D). Little is known about the dynamic behavior of such large vascular dilatations,3 and their potential for complications should always be considered, especially for patients in whom the symptoms are disproportionate to the hemodynamic impairment.